https://t.co/jM30g9iF16 (Updated) Chinese randomised phase III data Sorafenib maintenance confers OS advantage in AML FLT3ITD post transplant without adverse impact on NRM, or post transplant viral reactivations incidence.
Effect of #sorafenib maintenance on #EpsteinBarrVirus and #cytomegalovirus infections in patients with FLT3-ITD #AML undergoing allogeneic #hematopoietic #stemcell transplantation: a secondary analysis of a #randomizedclinicaltrial New at #BMCMedicine -
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial by Xin Xu https://t.co/lgQ
New article: Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized… https://t.co/SzTCfnNp5j #AM